Dennis C. Sgroi

48.4k citations

173 papers · 21.0k indexed · 8 hit papers · h-index 71

Cancer Research top 0.05%
- Breast Cancer Treatment Studies 51
- Cancer Genomics and Diagnostics 17
Oncology top 0.1%
- Cancer Cells and Metastasis 17
- Cancer-related Molecular Pathways 15
- HER2/EGFR in Cancer Research 14
Molecular Biology top 0.2%
Cell Biology top 0.2%
Immunology and Allergy top 0.5%
Genetics
- Estrogen and related hormone effects 28
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 23
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 17

Co-authors: Robert A. Weinberg Daniel A. Haber Piyush B. Gupta Andrea L. Richardson Vincent J. Carey Rizwan Naeem Fernando Arenzana‐Seisdedos Thierry Delaunay
Cited by: Cancer Research Oncology Molecular Biology
Journals: Science (1 paper)New England Journal of Medicine (5 papers)Cell (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Dennis C. Sgroi

168 papers receiving 20.6k citations

Hit Papers

8 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Science
2009 Breast Cancer Research
2008 Genes & Development
2006 Proceedings of the National Academy of Sciences
2005 Journal of Clinical Oncology
2005 Cell
2003 Proceedings of the National Academy of Sciences
2001 Cell

Peers

Countries citing papers authored by Dennis C. Sgroi

Since Specialization

Citations

This map shows the geographic impact of Dennis C. Sgroi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis C. Sgroi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis C. Sgroi more than expected).

Fields of papers citing papers by Dennis C. Sgroi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis C. Sgroi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis C. Sgroi. The network helps show where Dennis C. Sgroi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dennis C. Sgroi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dennis C. Sgroi Line = papers co-authored together Dennis C. Sgroi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial Clinical Cancer Research ·Eleftherios P. Mamounas,Hanna Bandos,Priya Rastogi,Yi Zhang,Kai Treuner,Peter C. Lucas,Charles E. Geyer,Louis Fehrenbacher,Stephen Chia,Adam Brufsky,Janice M. Walshe,Gamini S. Soori,Shaker R. Dakhil,Soonmyung Paik,Sandra M. Swain,Dennis C. Sgroi,Catherine A. Schnabel,Norman Wolmark	2024	7
2	Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study Clinical Cancer Research ·John M.S. Bartlett,Dennis C. Sgroi,Kai Treuner,Yi Zhang,Tammy Piper,Ranelle Salunga,Ikhlaaq Ahmed,Lucy Doos,Sarah Thornber,Karen J. Taylor,Elena F. Brachtel,Sarah Pirrie,Catherine A. Schnabel,Daniel Rea	2022	25
3	Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma Clinical Cancer Research ·Raquel Nunes,Tal Sella,Kai Treuner,Jennifer M. Atkinson,Jenna Wong,Yi Zhang,Pedro Exman,David J. Dabbs,Andrea L. Richardson,Catherine A. Schnabel,Dennis C. Sgroi,Steffi Oesterreich,Ashley Cimino‐Mathews,Otto Metzger	2021	13
4	FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer Clinical Cancer Research ·Joshua Z. Drago,Luigi Formisano,Dejan Juric,Andrzej Niemierko,Alberto Servetto,Seth A. Wander,Laura M. Spring,Neelima Vidula,Jerry Younger,Jeffrey Peppercorn,Megan Yuen,Giuliana Malvarosa,Dennis C. Sgroi,Steven J. Isakoff,Beverly Moy,Leif W. Ellisen,A. John Iafrate,Carlos L. Arteaga,Aditya Bardia	2019	47
5	Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer JAMA Oncology ·Ivana Šestak,Richard Buus,Jack Cuzick,Peter Dubsky,Ralf Kronenwett,Carsten Denkert,Sean Ferree,Dennis C. Sgroi,Catherine A. Schnabel,Frederick L. Baehner,Elizabeth Mallon,Mitch Dowsett	2018	204
6	A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes Clinical Cancer Research ·Yi Zhang,Brock E. Schroeder,Piiha-Lotta Jerevall,Amy Ly,Hannah Nolan,Catherine A. Schnabel,Dennis C. Sgroi	2017	34
7	AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth Molecular Cancer Therapeutics ·Cleidson P. Alves,Ipsita Dey‐Guha,Sheheryar Kabraji,Albert C. Yeh,Nilesh P. Talele,Xavier Solé,Joeeta Chowdhury,Mari Mino–Kenudson,Massimo Loda,Dennis C. Sgroi,Anne‐Lise Børresen‐Dale,Hege G. Russnes,Kenneth N. Ross,Sridhar Ramaswamy	2017	19
8	Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation Cancer Research ·Wayne Miles,Antonio Lembo,Angela Volorio,Elena F. Brachtel,Bin Tian,Dennis C. Sgroi,Paolo Provero,Nicholas J. Dyson	2016	44
9	Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Compositionbreakdown → Science ·Min Yu,Aditya Bardia,Ben S. Wittner,Shannon L. Stott,Malgorzata E. Smas,David T. Ting,Steven J. Isakoff,Jordan C. Ciciliano,Marissa Wells,Ajay M. Shah,Kyle Concannon,Maria Donaldson Collier,Lecia V. Sequist,Elena F. Brachtel,Dennis C. Sgroi,José Baselga,Sridhar Ramaswamy,Mehmet Toner,Daniel A. Haber,Shyamala Maheswaran	2013	1928
10	Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence Clinical Cancer Research ·Yi Zhang,Catherine A. Schnabel,Brock E. Schroeder,Piiha-Lotta Jerevall,Rachel C. Jankowitz,Tommy� Fornander,Olle Stål,Adam Brufsky,Dennis C. Sgroi,Mark G. Erlander	2013	163
11	Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker JNCI Journal of the National Cancer Institute ·Dennis C. Sgroi,Erin Carney,Elizabeth Zarrella,L. Steffel,Shemeica Binns,Dianne M. Finkelstein,Jackie Szymonifka,Atul K. Bhan,Lois E. Shepherd,Yi Zhang,Catherine A. Schnabel,Mark G. Erlander,James N. Ingle,Peggy L. Porter,Hyman B. Muss,Katherine I. Pritchard,Dongsheng Tu,David L. Rimm,Paul E. Goss	2013	153
12	A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas Clinical Cancer Research ·Meghan L. Rudd,Jessica C. Price,Sarah Fogoros,Andrew K. Godwin,Dennis C. Sgroi,Maria J. Merino,Daphne W. Bell	2011	170
13	Cancer Cell–Associated MT1-MMP Promotes Blood Vessel Invasion and Distant Metastasis in Triple-Negative Mammary Tumors Cancer Research ·Jean Yannis Perentes,Nathaniel D. Kirkpatrick,Satoshi Nagano,Eve Y. Smith,Christine M. Shaver,Dennis C. Sgroi,Igor Garkavtsev,Lance L. Munn,Rakesh K. Jain,Yves Boucher	2011	91
14	PIK3R1 (p85α) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer Cancer Research ·Mary Ellen Urick,Meghan L. Rudd,Andrew K. Godwin,Dennis C. Sgroi,Maria J. Merino,Daphne W. Bell	2011	162
15	The Integrin αvβ3-5 Ligand MFG-E8 Is a p63/p73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers Cancer Research ·Chuanwei Yang,Tetsu Hayashida,Nicole Forster,Cuiqi Li,Dejun Shen,Shyamala Maheswaran,Li Chen,Karen S. Anderson,Leif W. Ellisen,Dennis C. Sgroi,Emmett V. Schmidt	2010	58
16	Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin Molecular Cancer Research ·Jianmin Zhang,Young‐Han Song,Brian W. Brannigan,Doke C.R. Wahrer,Taryn A. Schiripo,Patricia L. Harris,Sara M. Haserlat,Lindsey E. Ulkus,Kristen Shannon,Judy E. Garber,Matthew L. Freedman,Brian E. Henderson,Lee Zou,Dennis C. Sgroi,Daniel A. Haber,Daphne W. Bell	2009	12
17	A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer Clinical Cancer Research ·Xiaojun Ma,Ranelle Salunga,Sonika Dahiya,Wilson Wang,Erin Carney,Virginie Durbecq,Adrian L. Harris,Paul E. Goss,Christos Sotiriou,Mark G. Erlander,Dennis C. Sgroi	2008	227
18	Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort Clinical Cancer Research ·Ben S. Wittner,Dennis C. Sgroi,Paula D. Ryan,Tako J. Bruinsma,Annuska M. Glas,Anitha Male,Sonika Dahiya,Karleen Habin,René Bernards,Daniel A. Haber,Laura J. van’t Veer,Sridhar Ramaswamy	2008	115
19	Frequent Met Oncogene Amplification in a Brca1/Trp53 Mouse Model of Mammary Tumorigenesis Cancer Research ·Gromoslaw A. Smolen,Beth Muir,Gayatry Mohapatra,Anne Barmettler,Woo Jae Kim,Miguel N. Rivera,Sara M. Haserlat,Ross A. Okimoto,Eunice L. Kwak,Sonika Dahiya,Judy E. Garber,Daphne W. Bell,Dennis C. Sgroi,Lynda Chin,Chu‐Xia Deng,Daniel A. Haber	2006	32
20	Identification of Cyclin D1– and Estrogen-Regulated Genes Contributing to Breast Carcinogenesis and Progression Cancer Research ·Chuanwei Yang,Sally Trent,Viviana Ionescu-Tiba,Lan Lan,Toshi Shioda,Dennis C. Sgroi,Emmett V. Schmidt	2006	64

About Dennis C. Sgroi

Dennis C. Sgroi is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 173 papers that have together received 21.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (51 papers), Estrogen and related hormone effects (28 papers), Advanced Breast Cancer Therapies (23 papers), Cancer Genomics and Diagnostics (17 papers), Breast Lesions and Carcinomas (17 papers), Cancer Cells and Metastasis (17 papers), Cancer-related Molecular Pathways (15 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Cancer Research (6.8k citations), Oncology (8.7k citations) and Molecular Biology (11.1k citations). Dennis C. Sgroi has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Robert A. Weinberg, Daniel A. Haber, Piyush B. Gupta, Andrea L. Richardson, Vincent J. Carey, Rizwan Naeem, Fernando Arenzana‐Seisdedos, Thierry Delaunay, Akira Orimo and Mark G. Erlander. Their work appears in journals such as Science, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact